Literature DB >> 2587954

The etiology of bacterial cellulitis as determined by fine-needle aspiration.

A F Sigurdsson1, S Gudmundsson.   

Abstract

Bacterial cellulitis is a common problem, etiologic diagnosis often unrewarding and opinions differ on empiric therapy. The purpose of this study was to determine the major microbiologic causes of bacterial cellulitis in a walk-in Emergency Room setting. 94 cases in 89 patients with clinical signs of cellulitis were studied. The infection was closed in 74 cases and associated with an open skin lesion in 22. The infection site was aspirated with a suction air-buffer technique employing a Cameco handle for easier handling and stabilization of the aspiration needle. After exclusion of contaminated samples, positive cultures were obtained from 30 cases (31.9%). Cultures were positive in 30.6% of open lesions and in 36.4% of closed ones. Staphylococcus aureus was the most common organism, present in 11 cases, S. epidermidis in 8 and group A beta-hemolytic streptococci in 5. All S. aureus strains were methicillin-sensitive and only 1 was sensitive to penicillin. The most common site of infection was the lower extremity (59%). According to these data the optimal initial therapy for bacterial cellulitis in adults should be with drugs active against both staphylococci and streptococci.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2587954     DOI: 10.3109/00365548909037882

Source DB:  PubMed          Journal:  Scand J Infect Dis        ISSN: 0036-5548


  13 in total

1.  Diagnosis of cellulitis in the immunocompromised host.

Authors:  C F Carey; L Dall
Journal:  Can J Infect Dis       Date:  1990

Review 2.  National Athletic Trainers' Association Position Statement: Management of Acute Skin Trauma.

Authors:  Joel W Beam; Bernadette Buckley; William R Holcomb; Mario Ciocca
Journal:  J Athl Train       Date:  2017-01-16       Impact factor: 2.860

Review 3.  Development of a vaccine against Staphylococcus aureus.

Authors:  Brad Spellberg; Robert Daum
Journal:  Semin Immunopathol       Date:  2011-11-14       Impact factor: 9.623

4.  Factors associated with complications and mortality in adult patients hospitalized for infectious cellulitis.

Authors:  J Carratalà; B Rosón; N Fernández-Sabé; E Shaw; O del Rio; A Rivera; F Gudiol
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-03-05       Impact factor: 3.267

Review 5.  A practical guide to the treatment of complicated skin and soft tissue infections.

Authors:  Horatio B Fung; Joanne Y Chang; Stephen Kuczynski
Journal:  Drugs       Date:  2003       Impact factor: 9.546

6.  Gram-negative bacillary cellulitis in patients with hepatic cirrhosis.

Authors:  J M Corredoira; J Ariza; R Pallarés; J Carratalá; P F Viladrich; G Rufí; R Verdaguer; F Gudiol
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-01       Impact factor: 3.267

7.  Antibiotic prescribing practices in a multicenter cohort of patients hospitalized for acute bacterial skin and skin structure infection.

Authors:  Timothy C Jenkins; Bryan C Knepper; S Jason Moore; Sean T O'Leary; Carla C Saveli; Sean W Pawlowski; Daniel M Perlman; Bruce D McCollister; William J Burman
Journal:  Infect Control Hosp Epidemiol       Date:  2014-08-20       Impact factor: 3.254

8.  Microbiological evaluation of infected wounds of the extremities in 214 adults.

Authors:  L Holzapfel; T Jacquet-Francillon; J Rahmani; P Achard; E Marcellin; T Joffre; P Y Lallement; A Bousquet; S Devaux; A Coupry
Journal:  J Accid Emerg Med       Date:  1999-01

9.  Appropriateness of antibiotic management of uncomplicated skin and soft tissue infections in hospitalized adult patients.

Authors:  Thomas L Walsh; Lynn Chan; Chelsea I Konopka; Michael J Burkitt; Matthew A Moffa; Derek N Bremmer; Monika A Murillo; Courtney Watson; Noreen H Chan-Tompkins
Journal:  BMC Infect Dis       Date:  2016-11-29       Impact factor: 3.090

Review 10.  Platelets in defense against bacterial pathogens.

Authors:  Michael R Yeaman
Journal:  Cell Mol Life Sci       Date:  2009-12-15       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.